Skip to main content
. 2022 Nov 3;41(2):315–322. doi: 10.1016/j.vaccine.2022.10.079

Fig. 2.

Fig. 2

Self-reported systemic reactions or additional symptoms and corresponding healthcare utilization within 14 days following BNT162b2 vaccination among children aged 5–11 years, by dose.